Travere Therapeutics Inc. (tvtx 2.5 09/15/25)
13F holders, Q1 2024 (March 31)1holders
$7.71avg. 13F price*
At the end of Q1 2024, 1 institutions reported holding Travere Therapeutics Inc. (tvtx 2.5 09/15/25) in their 13F filings. The largest holder was Pennant Investors, LP ($430K).
- Company
- Travere Therapeutics Inc. (tvtx 2.5 09/15/25)
- CUSIP
- 761299AB2
- Latest filing quarter
- Q1 2024
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $430K |
| Exits | 0 | $0 |
Ownership 1 holders
| Pennant Investors, LP | 0.12% | New | 55,800 | $430K |
"% of holder's portfolio" is TRAVERE THERAPEUTICS INC (TVTX 2.5 09/15/25)'s weight in each manager's 13F, not the share of Travere Therapeutics Inc. (tvtx 2.5 09/15/25) the manager owns.